Anaesthetic Management of a Patient With Immune-Mediated Necrotizing Muscle Disease With the Use of a Novel Ultrashort-Acting Benzodiazepine, Remimazolam: A Case Report

被引：2

作者：

Ogino, Hitoshi ^{[1
]}

Sugiyama, Daisuke ^{[1
]}

Ueda, Kenichi ^{[1
]}

机构：

[1] Kameda Med Ctr, Anaesthesiol, Kamogawa, Japan

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 04期

关键词：

Categories; Anesthesiology; Neurology; intravenous anesthesia; myopathy; remimazolam; imnm; immune-mediated necrotizing muscle disease;

D O I：

10.7759/cureus.37326

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We reported the anesthetic management of remimazolam, a novel ultra-short-acting benzodiazepine, for a 21-month-old female with immune-mediated necrotizing myopathy (IMNM). Remimazolam has a similar chemical structure to midazolam but possesses a unique side chain that reduces its propensity to accumulate in the body, thereby minimizing prolonged sedation or respiratory depression. Our experience supports that remimazolam could be a suitable agent for anesthetizing the patient with IMNM.

引用

页数：4

共 2 条

[1] Spontaneous Development of Immune-Mediated Necrotizing Myopathy (IMNM) After Chronic Use of Statins: A Case Report
Luong, Michael T.
Danahy, Paul
Ho, Gerald Y.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
[2] Immune-Mediated Necrotizing Myopathy With Concurrent Statin Use After Routine COVID-19 Inoculation: A Case Report
Mufti, Zarmina
Dietz, Nicholas
Pearson, Luke
Fortuny, Enzo
Mettille, Jersey
Ding, Dale
Brown, Martin
Mufti, Harris
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)

← 1 →